[1]DAWSON LP, LUM M, NERLEKER N, et al. Coronary atherosclerotic plaque regression: JACC State-of-the-Art Review[J]. J Am CollCardiol, 2022, 79: 66-82. [2]MINTZ GS, GUAGLIUMI G. Intravascular imaging in coronary artery diseases[J]. Lancet, 2017, 390:793-809. [3]桂家辉,黄林,裘耀阳,虎学强,李勤. 血管内光学相干层析成像技术在冠状动脉粥样硬化斑块检测方面的应用[J].基础医学与临床,2022,42: 360-365. [4]AHMADI A, ARGULIAN E, Leipsic J, et al. From subclinical atherosclerosis to plaque progression and acute coronary events: JACC State-of-the-Art Review [J]. J Am Coll Cardiol, 2019, 74: 1608-1617. [5]张爽, 李之凡, 钱杰, 吴娜琼. 腔内影像学方法评价降脂治疗对冠状动脉粥样硬化斑块影响的研究进展[J]. 基础医学与临床,2022,42: 366-371. [6]DI MICCO R, KRIZHANOVSKY V, BAKER D, et al. Cellular senescence in ageing: from mechanisms to therapeutic opportunities [J]. Nat Rev Mol Cell Biol, 2021, 22: 75-95. [7]张琦悦,张伟丽. 血管老化在动脉粥样硬化中的研究进展[J].基础医学与临床,2022,42: 372-377. [8]NIU N, XU S, XU Y, et al. Targeting mechanosensitive transcription factors in atherosclerosis [J]. Trends Pharmacol Sci, 2019, 40: 253-266. [9]赵川榕,周菁. 剪切力敏感关键分子的动脉粥样硬化靶向防治研究[J].基础医学与临床,2022,42: 378-383. [10]韩爽,陈宇,张伟丽. miR-216a对人外周血单个核细胞衍生的巨噬细胞特性的影响[J]. 基础医学与临床,2022,42: 384-388. |